Updated:
Corza Health
Greg Lucier founded Corza Health with GTCR to buy and build healthcare and life sciences companies, applying his NuVasive and Life Technologies playbook.
Corza Health
Lucier launched Corza Health in partnership with GTCR, the private equity firm known for its Leaders Strategy of backing executives to acquire and scale companies. The Del Mar-based platform targets healthcare and life sciences businesses, with a stated focus on surgical and medical products through its Corza Medical unit. Lucier's career spans CEO roles at NuVasive, a spine surgery technology company, and Life Technologies, which he built into a $15B acquisition target for Thermo Fisher Scientific. Corza Health provides growth capital and operational expertise to portfolio companies. The firm's model emphasizes installing leadership teams, driving efficiencies through proprietary metrics, building M&A capabilities for buy-and-sell transactions, and supporting public exits. Its Corza Medical division supplies surgical tools and materials across specialties, while the broader platform invests in healthcare companies that deliver better financial, operational, and clinical outcomes. Geographic reach includes offices in Southern California and Colorado. Lucier runs the firm, drawing on a network built over three decades at General Electric, Invitrogen, and NuVasive. He also serves on boards including Catalent, Dentsply Sirona, and Maravai LifeSciences. GTCR contributes its own network of executives and industry relationships to source deals and support portfolio growth. Corza Health operates as a permanent-capital vehicle rather than a traditional fund — it does not disclose AUM or raise capital from outside limited partners. The structure pairs a single-family-office-level commitment to long holding periods with the operational intensity of a private equity firm, making it a hybrid model uncommon in healthcare investing.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Del Mar
Corporate office
2010 Jimmy Durante Blvd, Suite 240, Del Mar, CA 92014, United States
Additional offices
Colorado, United States
Principals
Greg Lucier
Chief Executive Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Corza Health?
Greg Lucier, the founder and CEO, leads investment decisions. He brings experience as former CEO of NuVasive and Life Technologies, and earlier as an executive at GE Healthcare. The firm's partnership with GTCR provides additional sourcing and operational support.
Is Corza Health structured as a family office or a private equity firm?
Corza Health operates as a hybrid. It is a permanent-capital vehicle formed with GTCR, meaning it does not raise traditional blind-pool funds from outside limited partners. This gives it flexibility to hold investments longer than a standard PE fund.
Does Corza Health participate in fund commitments or only direct deals?
Corza Health makes direct investments in healthcare and life sciences companies. There is no public information indicating the firm makes fund commitments or invests as a limited partner in other managers' vehicles.
What investment stages does Corza Health target?
The firm focuses on established companies that can benefit from operational improvement, add-on acquisitions, and growth capital. It does not market itself as an early-stage venture investor but rather a partner for businesses seeking market-leader status and eventual public exit.
How is Corza Health related to GTCR?
GTCR is Corza Health's founding and primary financial partner. The private equity firm's Leaders Strategy model aligns executives like Greg Lucier with its own capital and deal-sourcing network. GTCR itself is a Chicago-based firm managing over $30 billion in equity commitments.
Where does Corza Health's capital come from?
The capital base is not publicly disclosed. It is understood to combine GTCR's balance-sheet commitments with Lucier's own capital, structured as a long-term partnership rather than a traditional fund with external investors.
Which sectors does Corza Health explicitly avoid?
No explicit sector exclusions are stated. The firm's public-facing focus is healthcare and life sciences, with a dedicated Corza Medical unit serving surgical providers. Non-healthcare sectors appear outside its mandate.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: